The Daily Beast

The Best-Selling Stanley Quencher Is Back in Stock at Amazon

The beloved tumbler has been flying off the shelves for months. Now’s the time to see what the hype is all about before they sell out again.

The Daily Beast

Steve Bannon’s Legal Woes Just Got Even Messier

Steve Bannon has been at war with some of his former lawyers over unpaid legal bills. It turns out, there’s a lot more going on than Bannon just stiffing his legal team.

The Daily Beast

Subway Vigilante Daniel Penny Indicted for Death of Jordan Neely: Report

Penny, who choked Jordan Neely to death on a New York City subway train last month, has been indicted by a Manhattan grand jury.

The Daily Beast

Miracle Boats Secretly Snatch Families Putin Left to Drown

A miraculous rescue operation taking place under Putin’s nose has saved dozens of flooding victims. But they have horror stories to share.

ScienceDaily

Sweet salvation -- how a sugar cane pathogen is gearing up a new era of antibiotic discovery

A potent plant toxin with a unique way of killing harmful bacteria has emerged as one of the strongest new antibiotic candidates in decades.

ScienceDaily

Co-creating health for humanity: New trends in pharmaceutical interorganizational deals: Are new interorganizational deal networks the key to improving drug discovery and R&D productivity in the pharmaceutical industry?

Discovering new drugs has become increasingly rare for independent large pharmaceutical companies in recent times. Almost 60% of new drugs are discovered through mergers and acquisitions and drug licensing. Now, researchers shed light on the recent trends of spinouts from academia and investments in the U.S.A and Europe, foreshadowing a promising shift in the industry's interorganizational deal networks to improve research and development productivity in the future.

ScienceDaily

Targeting cancer with a multidrug nanoparticle: Using bottlebrush-shaped particles, researchers can identify and deliver synergistic combinations of cancer drugs.

Chemists designed a bottlebrush-shaped nanoparticle that can be loaded with multiple drugs, in ratios that can be easily controlled. Using these particles, the researchers calculated and delivered the optimal ratio of three cancer drugs used to treat multiple myeloma.

ScienceDaily

Study shows FDA-approved TB regimen may not work against the deadliest form of TB due to multidrug-resistant strains

Findings in animal models show that a U.S. Food and Drug Administration (FDA)-approved antibiotic regimen for multidrug-resistant (MDR) tuberculosis (TB) may not work for TB meningitis.

ScienceDaily

Artificial intelligence aids discovery of super tight-binding antibodies: Scientists could accelerate the development of new antibody drugs

Scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.

ScienceDaily

Catching the wrongdoers in the act: Chemists develop a novel tool to decipher bacterial infections in real time

A research team has developed a novel chemical tool to reveal how bacteria adapt to the host environment and control host cells. This tool can be used to investigate bacterial interactions with the host in real-time during an infection, which cannot be easily achieved by other methods.

« PREVIOUS3NEXT »